FOR IMMEDIATE RELEASE
Hepatitis B Foundation Hosts Leadership from the Centers for Disease Control and Prevention (CDC)
Pictured from left to right: Dr. John Ward, CDC director DVH; Dr. Baruch Blumberg, Nobel laureate; Mr. Dan Riedford, CDC deputy director DVH; and Dr. Tom London, HBF chief medical advisor, at the Hepatitis B Foundation (Jan. 25, 2008).
DOYLESTOWN, PA (February 1, 2008) –The Hepatitis B Foundation hosted Dr. John Ward, Director, CDC Division of Viral Hepatitis (DVH), and Mr. Dan Riedford, Deputy Director, to tour its research facilities, learn about our new Gateway to Care initiative, and discuss priority issues in the control and care of hepatitis B. The CDC visit was timed to coincide with Nobel laureate Dr. Baruch Blumberg’s monthly visit to the foundation where he serves as its Distinguished Scholar.
The Hepatitis B Foundation (HBF) was pleased to share with the CDC leadership details about its new public health initiative, titled “Gateway to Care”, which seeks to create a comprehensive model of care for individuals diagnosed with chronic hepatitis B.
“With an estimated one million people worldwide dying each year from the complications of hepatitis B, which includes more than 5,000 Americans, there is an urgent need to develop effective programs to help close the gap between diagnosis and referral to care in order to reduce the burden of disease and most importantly, to save lives,” says Dr. Timothy Block, HBF President.
The HBF and CDC agree that great success has been achieved in the prevention of hepatitis B, particularly among infants and children up to18 years; however, there remains a tremendous gap in access to care for those affected. The foundation’s new Gateway campaign will help identify specific barriers to care, create culturally competent outreach and educations programs, and establish an effective referral system to providers who are knowledgeable about the management and treatment of hepatitis B. The foundation’s campaign will be based in Philadelphia, but the ultimate goal is to create a model that can be duplicated across the nation to improve access to care for those living with chronic hepatitis B.
About the Hepatitis B Foundation
The Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. The Foundation is located in the new Pennsylvania Biotechnology Center, which it created to expand and accelerate its research mission. For more information, visit www.hepb.org or call (215) 489-4900.